We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Credit Card-Size Microflow System Designed to Tackle Thousands of Experiments

By LabMedica International staff writers
Posted on 27 Aug 2010
Print article
Tens of thousands of chemical and biochemical experiments may soon be conducted daily with the use of a microflow system of the size of a credit card. The device has already been tested in research on the effectiveness of antibiotic mixtures.

A group of scientists from the Institute of Physical Chemistry of the Polish Academy of Sciences (IPC PAS; Warsawl), headed by D.Sc. Piotr Garstecki, built a microflow system allowing the streams of drops containing various solutions to merge. The new system makes it possible to produce and precisely control concentrations of reaction micromixtures, and it operates several times faster and with smaller volumes of liquids than the microtitre plate method currently popular at laboratories. "The device developed by us will allow even tens of thousands of biochemical experiments to be conducted daily,” noted Dr. Garstecki. The microlab may considerably affect the way in which experiments are performed with respect to chemical synthesis and medical diagnostics and biotechnologies.

The microflow system constructed in the IPC PAS is a miniature chemical reactor with the size of a credit card. Reactions proceed inside tiny drops moving along specially designed, small channels. Volumes of the drops are controlled with the use of a computer and are typically equal to about one microliter. The system can work at a speed that allows mixing three drops per second. Moreover, instead of micro valves, which it is difficult to construct, scientists used inexpensive typical big valves that they placed outside the device. "Miniaturization of everything is simply not economical. Taking the valves outside the microsystem, the chip itself can be made simple, cheap, and disposable. The most important thing is that the chemical reactions themselves proceed in a microscale under precisely controlled conditions,” explained Krzysztof Churski, a Ph.D. student.

The invention of researchers from the Institute of Physical Chemistry of the PAS already has a potential to influence significantly the development of many areas of chemistry and medicine, in particular screening. Currently, screening is performed with the use of microtiter plates--plates with several hundreds of wells filled in by a robotic handler. In this type of research cost of a single reaction reaches approximately US$3, but the value of reagents is about $0.20; the remaining part is the cost of maintenance of apparatus and its infrastructure. Since in a typical project to search for a new drug the number of tested compounds ranges from several hundreds to as many as several millions, the costs can reach millions of dollars. "Our microflow system not only reduce all costs but also significantly shortens the time necessary to conduct research,” emphasized Dr. Garstecki.

The microflow system from the IPC PAS may be especially useful in searching for new medicines, particularly composed of several antibiotics. Pairs of antibiotics typically have stronger (synergistic pairs) or weaker (antagonistic pairs) effect than each of their components individually. However, it is particularly interesting that certain antagonistic pairs show high effectiveness in fighting microorganisms, which cannot be easily predicted. The existing laboratory methods allow for description of such pairs but demand conducting a huge number of labor-intensive experiments. The apparatus constructed at the IPC PAS can quickly identify the interesting pairs of antibiotics that could prevent one of the basic problems of modern medicine--the creation of drug-resistant strains.

Tests conducted in the Institute of Physical Chemistry of the PAS allowed scientists to demonstrate the operation of the microflow system in the conditions simulating the run of automated screening. Each microdrop merged with two microdrops of antibiotics, chloramphenicol and tetracycline, and the volumes of the former two were altered dynamically, which regulated the proportions between the drugs. The drops mixed in the microflow system were left for three hours in order to incubate bacteria. Then the intensity of light emitted by metabolism markers was analyzed, which allowed vitality of colonies in individual drops to be easily determined. The whole process was automated and revealed that the mixture of the antibiotics examined is the least effective where the proportion of the components is equal.

Microflow techniques are seen as the future of chemical engineering. They go back to the 1990s when the works on the first systems of channels began. At that time, liquids with chemical reagents were let through the channels with diameters of a tenth or hundredth of a millimeter. Where small volumes are used, the flow is laminar and it is subject to effects related to viscosity, which makes it easier to control the run of the reaction (macroscale flows are frequently dominated by inertia and turbulence). Systems producing drops are simple and inexpensive, substances in microchannels mix very well and their flow is usually caused by the difference in pressure, i.e., a physical phenomenon that does not influence the chemical composition of a liquid (contrary to, for instance, flows that are caused by an electric field). In the future, the volume of drops can be reduced to nanoliters or even pictoliters. Many scientists agree that microflow systems will change the nature of modern chemistry as dramatically as integrated circuits changed electronics in the 1970s.

Related Links:

Institute of Physical Chemistry of the Polish Academy of Sciences



Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
Automated Blood Typing System
IH-500 NEXT
New
Laboratory Electric Thermostat
DNP-9025A
New
Flu Test
ID NOW Influenza A & B 2

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The artificial intelligence models can personalize immune therapies in oncology patients (Photo courtesy of 123RF)

AI Tool Identifies Novel Genetic Signatures to Personalize Cancer Therapies

Lung cancer and bladder cancer are among the most commonly diagnosed cancers globally. Researchers have now developed artificial intelligence (AI) models designed to personalize immune therapies for oncology... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.